The People’s Prescription: Re-imagining health innovation to deliver public value
This report aims to set out a vision for a health innovation model that is driven by public health need and delivers products at prices that patients and health systems can afford. The report presents a thorough analysis of the way biomedical research and development (R&D) is currently conducted, highlighting how market-driven agendas and public health priorities are too often misaligned. This can result in both unaffordable medicines and gaps in the research for urgent, but unprofitable, health needs. Using examples of alternative approaches to health innovation from around the world, this report demonstrates that effective alternatives do exist.
These examples show that with a mission-oriented approach and a dynamic division of labour between public and private actors, public health-driven innovation can flourish. While there is no one-size-fits-all overarching policy put forward, the examples form a strong starting point for how health innovation could be re-imagined to deliver better public value.